MedTrace Logo

Effects Of Otago Exercise Versus Multisensory Integration Training On Balance And Gait In Elderly With Diabetes

NCT07776535 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-08-20

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effect of the Otago exercise and Multisensory integration training on balance and gait in the elderly with type 2 diabetes mellitus.

The main question it aims to answer is:

• Is there a significant difference between the effect of Otago exercise and Multisensory integration training on balance and gait in the elderly with type 2 diabetes mellitus? Researchers will compare Otago exercise to Multisensory integration training to know which one has the greatest benefit on balance \&gait in the elderly with type2 diabetes.

Participants will be divided into 3 groups; each group takes a certain training program for 8 weeks:

* First group: Otago exercise group plus conventional treatment for neuropathy.
* Second group: Multisensory integration training group plus conventional treatment for neuropathy.
* Third group: control group takes only conventional treatment for neuropathy.

Conditions

Interventions

OTHER

Otago exercise

Exercise program consisted of ( flexibilty - strengthening - balance ) exercise for elderly. Time of each session (50:60 min). For 3d/w for 8weeks.

OTHER

Multisensory integration training

Multisensory integration training is a group of balance exercise depend on facilitating different sensory systems (visual-vestibular-propioception) Time for each session (50 min). For 3d/w for 8weeks.

OTHER

conventional treatment for neuropathy

conventional treatment for improving balance and gait problem associated with DPN For 3d/w for 8weeks

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Gehad Ali Abd-Elhasseb, Assistant Professor · Cairo University

  • Fatma Younis Mahmoud Abd-Elsalam, Lecturer of Physical Therapy · Cairo University

  • Eman Mohamed El-Sayed Deif, consultant internal medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2027-10-31
Completion
2027-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07776535 on ClinicalTrials.gov